Skip to content

A Nurse-led Coaching Programme With Telemonitoring in Heart Failure

A Nurse-led Coaching Programme With Telemonitoring in Heart Failure: Protocol for a Randomized Controlled Feasibility Study

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06285565
Acronym
INTERCOACH
Enrollment
46
Registered
2024-02-29
Start date
2024-09-17
Completion date
2025-12-15
Last updated
2026-03-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Feasibility, Heart Failure, Hospitalizations, Mentoring, Telemonitoring

Brief summary

The goal of this pilot interventional study is to assess the feasibility and acceptability of a supportive intervention for patients affected by heart failure. The main questions it aims to answer are: * Are implementation strategies effective in facilitating participant fidelity? * What factors contribute to patients' satisfaction with the designed intervention, and how can these be optimized for improved patient experience and adherence? * Are the methods and tools established the most appropriate to ensure the completeness of the data collection? Participants will follow a combined intervention consisting of: 1. pre-discharge educational meeting; 2. telephone nurse-led coaching sessions; 3. home telemonitoring of vital signs. In the main trial, researchers will compare data from the intervention group with a control group to assess whether it reduces hospitalization rates and improves self-care capabilities

Interventions

COMBINATION_PRODUCTNurse-led telephone coaching intervention with home telemonitoring of vital signs

In addition to standard care, the intervention group will receive a nurse-led supportive programme that involves a pre-discharge educational meeting and 6-month telephone coaching sessions. Patient's caregivers will also be invited to participate. After discharge, patients will be asked to measure their vital signs, daily. In case of alteration, the nurse will ascertain the presence of congestion symptoms and decide to reinforce the recommendations for self-management, request a specialist medical consultant, or refer to the emergency services

Sponsors

Alberto Dal Molin
Lead SponsorOTHER
Azienda Ospedaliero Universitaria Maggiore della Carita
CollaboratorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
SINGLE (Outcomes Assessor)

Masking description

The assessors will collect clinical outcomes by telephone and will be blinded to the group assignment

Intervention model description

A parallel, open-label randomized controlled feasibility study

Eligibility

Sex/Gender
ALL
Age
65 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* aged 65 and over * hospitalized for cardiac decompensation, regardless of ejection fraction (FE) value (preserved or decreased) * expected to be discharged home will be considered eligible.

Exclusion criteria

* Individuals who lack the cognitive and/or physical capabilities (Mini-COG +) for self-monitoring of vital signs, and without a caregiver available to assist them * people who receive other medical services

Design outcomes

Primary

MeasureTime frameDescription
Recruitment rate6 monthsthe proportion of patients who agreed to participate relative to those who fulfilled the inclusion criteria.
Retention rate6 monthsthe proportion of patients who complete the study and those who consent to participate
Adherence to the coaching intervention4 months.the number of coaching phone calls scheduled and actualized
Adherence to telemonitoring program4 months.the proportion of days during which vital signs were measured and sent by the system relative to the total duration of the intervention
Completeness of data collectionbaseline, after 3 and 6 monthsnumber of returned questionnaires.

Secondary

MeasureTime frameDescription
90- and 180-day General Practioner visitsData collection is planned at 3 and 6 months.
90- and 180-day oupatient visitsData collection is planned at 3 and 6 months.
Self-care capacity (Self-Care of Heart Failure Index )Data collection is planned at baseline, 3 and 6 months.The self-care capacity of the patient encompasses three dimensions: self-care maintenance, self-care monitoring and symptom perception, and self-care management
Self Care - Self-Efficacy ScaleData collection is planned at baseline, 3 and 6 months.Self-care capacity is mediated by self-efficacy perception, which is the individual's belief in their ability to achieve certain goals as a result of their actions, regardless of the challenges and difficulties they may face. A scale consisting of 10 items using a 5-response Likert scale will be utilized
Quality of life (SF-12 scale)Data collection is planned at baseline, 3 and 6 months.The quality of life is a value that integrates objective indicators (physical health, personal circumstances, social relationships, social and economic influences) and subjective ones (such as how the individual responds to objective conditions) related to various dimensions of life and personal values
Anxiety (Hamilton Anxiety Scale )Data collection is planned at baseline, 3 and 6 months.The detection of anxiety symptoms (psychological and somatic).
Heart Failure Somatic Perception Scale v.3 (HFSPS)Data collection is planned at baseline, 3 and 6 months.The detecion of somatic symptoms of the disease
Depression (Geriatric Depression Scale)Data collection is planned at baseline, 3 and 6 months.The detection of depressive symptoms of the elderly
MortalityData collection is planned at 3 and 6 months.
90- and 180-day all-cause hospital readmissionsData collection is planned at 3 and 6 months.
90- and 180-day heart failure-related hospital readmissionsData collection is planned at 3 and 6 months.
90- and 180-day Emergency Departments visitsData collection is planned at 3 and 6 months.

Countries

Italy

Contacts

STUDY_CHAIRINES BASSO, Dr

Università degli Studi del Piemonte Orientale Amedeo Avogadro

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 6, 2026